Articles by Disease (Tuberculosis, Cardiovascular)

Novel Drugs Targeting the c-Ring of the F₁F_O-ATP Synthase

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 16
Page: 815-824
Author(s): Alessandra Pagliarani, S. Nesci and V. Ventrella

Recent Advances Using Phosphodiesterase 4 (PDE4) Inhibitors to Treat Inflammatory Disorders: Animal and Clinical Studies

Journal: Current Drug Therapy
Volume: 11
Page: 21-40
Author(s): Chih-Hung Lin, Shu-Hao Chang and Jia-You Fang*

Opportunities and Challenges for Host-Directed Therapies in Tuberculosis

Journal: Current Pharmaceutical Design
Volume: 22
Page: 2599-2604
Author(s): Madhur Sachan, Ashish Srivastava, Rajeev Ranjan, Anuradha Gupta, Sanketkumar Pandya and Amit Misra

A New Era of Pulmonary Delivery of Nano-antimicrobial Therapeutics to Treat Chronic Pulmonary Infections

Journal: Current Pharmaceutical Design
Volume: 22
Page: 2577-2598
Author(s): Zahra Merchant, Graham Buckton, Kevin M.G. Taylor, Paul Stapleton, Imran Y. Saleem, Mohammed G. Zariwala and Satyanarayana Somavarapu

Microbiome Regulation of Autoimmune, Gut and Liver Associated Diseases

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 14
Page: 84-93
Author(s): Bhagirath Singh, Nan Qin and Gregor Reid

Cinnamic Acid Derivatives as Inhibitors of Oncogenic Protein Kinases – Structure, Mechanisms and Biomedical Effects#

Journal: Current Medicinal Chemistry
Volume: 23
Page: 954-982
Author(s): Marcin Mielecki and Bogdan Lesyng

Drug-induced Inhibition and Trafficking Disruption of ion Channels: Pathogenesis of QT Abnormalities and Drug-induced Fatal Arrhythmias

Journal: Current Cardiology Reviews
Volume: 12
Page: 141-154
Author(s): Luigi X. Cubeddu